Moderna Pharma

v1.0.0

Moderna Pharma specializes in mRNA technology to rapidly develop vaccines and therapies for COVID-19, cancer, and rare diseases.

⭐ 0· 48·0 current·0 all-time

by@hanxueyuan

OpenClaw Prompt Flow

Install with OpenClaw

Best for remote or guided setup. Copy the exact prompt, then paste it into OpenClaw for hanxueyuan/moderna-pharma.

Previewing Install & Setup.

Prompt PreviewInstall & Setup

Install the skill "Moderna Pharma" (hanxueyuan/moderna-pharma) from ClawHub.
Skill page: https://clawhub.ai/hanxueyuan/moderna-pharma
Keep the work scoped to this skill only.
After install, inspect the skill metadata and help me finish setup.
Use only the metadata you can verify from ClawHub; do not invent missing requirements.
Ask before making any broader environment changes.

Command Line

CLI Commands

Use the direct CLI path if you want to install manually and keep every step visible.

OpenClaw CLI

Bare skill slug

openclaw skills install moderna-pharma

ClawHub CLI

Package manager switcher

npx clawhub@latest install moderna-pharma

Security Scan

VirusTotal

Benign

View report →

OpenClaw

Benign

high confidence

✓

Purpose & Capability

The name/description claim an informational/company profile about Moderna and mRNA technology; the skill contains only a company timeline, business analysis, and usage triggers for topical research. No credentials, binaries, or external services are requested that would be unrelated to that purpose.

✓

Instruction Scope

SKILL.md contains static content (summary, timeline, analysis) and 'read_when' triggers. It does not instruct the agent to run commands, read files, access environment variables, or transmit data to external endpoints. Scope is limited to providing informational content.

✓

Install Mechanism

No install spec and no code files are present. As an instruction-only skill, nothing is written to disk or fetched at install time.

✓

Credentials

No environment variables, credentials, or config paths are requested. There are no disproportionate or unexplained secret requirements.

✓

Persistence & Privilege

always is false and the skill is user-invocable; it does not request permanent presence or system-wide modifications. Normal autonomous invocation is allowed by platform default but presents no additional risk here because the skill is read-only.

Assessment

This skill is essentially static reference material about Moderna and mRNA tech and poses low technical risk because it has no code, installs, or credential access. However: (1) the source/publisher are unknown — treat factual claims as potentially outdated or incomplete and verify against authoritative sources before making decisions, especially medical or financial ones; (2) do not rely on this skill as a substitute for professional medical, legal, or investment advice; (3) if you require provenance or an auditable source, ask the publisher for citations or prefer skills from verifiable publishers.

Like a lobster shell, security has layers — review code before you run it.

latestvk976hqseqvkjsehbpjy3payr8585hajm

48downloads

0stars

1versions

Updated 2d ago

v1.0.0

MIT-0

Moderna Pharma

历史时间线

2010: Moderna Therapeutics 在马萨诸塞州剑桥创立
2018: 纳斯达克上市（MRNA），创生物技术 IPO 纪录
2020: 1 月收到新冠病毒基因序列，2 月完成疫苗设计
2020 年 12 月: mRNA-1273 获 FDA 紧急使用授权
2022: 推进个性化癌症疫苗（mRNA-4157）与默克合作
2023: 新冠疫苗收入骤降，聚焦 RSV、流感和癌症疫苗管线

商业模式

mRNA 平台+产品管线模式：核心 mRNA 技术平台可快速开发针对各种疾病的疫苗和疗法。收入来自新冠疫苗销售、合作研发付款、政府合同。未来增长取决于非新冠疫苗管线的临床成功。

护城河分析

mRNA 平台技术：拥有广泛的 mRNA 递送（LNP）专利组合；速度优势：从基因序列到临床样品只需数周；临床数据积累：超 20 亿剂接种积累了庞大安全性数据

关键数据

2023 年营收约 68 亿美元；新冠疫苗全球销量超 7 亿剂；市值约 500 亿美元；管线中超过 40 个临床项目

有趣事实

Moderna 的名字来自 Modified RNA（修饰 RNA）。公司创立时就坚信 mRNA 可以成为软件平台——同样的技术基础，只需改变遗传代码就能治疗不同疾病。

Comments

Loading comments...